MStern Blotting-High Throughput Polyvinylidene Fluoride (PVDF) Membrane-Based Proteomic Sample Preparation for 96-Well Plates

被引:59
作者
Berger, Sebastian T. [1 ,2 ,4 ,5 ]
Ahmed, Saima [1 ,2 ,4 ,5 ]
Muntel, Jan [1 ,2 ,4 ,5 ]
Polo, Nerea Cuevas [1 ,2 ,4 ,5 ,6 ]
Bachur, Richard [3 ]
Kentsis, Alex [7 ,8 ]
Steen, Judith
Steen, Hanno [1 ,2 ,4 ,5 ]
机构
[1] Boston Childrens Hosp, Prote Ctr, Boston, MA 02115 USA
[2] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA
[3] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA
[4] Boston Childrens Hosp, F M Kirby Neurobiol Ctr, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
[6] Univ Milan, Dept Vet Sci & Publ Hlth, I-20122 Milan, Italy
[7] Cornell Univ, Mem Sloan Kettering Canc Ctr, Dept Pediat, Mol Pharmacol & Chem Program,Sloan Kettering Inst, New York, NY 10021 USA
[8] Weill Med Coll, New York, NY USA
关键词
DIGESTION;
D O I
10.1074/mcp.O115.049650
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We describe a 96-well plate compatible membrane-based proteomic sample processing method, which enables the complete processing of 96 samples (or multiples thereof) within a single workday. This method uses a large-pore hydrophobic PVDF membrane that efficiently adsorbs proteins, resulting in fast liquid transfer through the membrane and significantly reduced sample processing times. Low liquid transfer speeds have prevented the useful 96-well plate implementation of FASP as a widely used membrane-based proteomic sample processing method. We validated our approach on whole-cell lysate and urine and cerebrospinal fluid as clinically relevant body fluids. Without compromising peptide and protein identification, our method uses a vacuum manifold and circumvents the need for digest desalting, making our processing method compatible with standard liquid handling robots. In summary, our new method maintains the strengths of FASP and simultaneously overcomes one of the major limitations of FASP without compromising protein identification and quantification.
引用
收藏
页码:2814 / 2823
页数:10
相关论文
共 21 条
  • [1] [Anonymous], 2011, SAMPLE PREPARATION B
  • [2] MS-Viewer: A Web-based Spectral Viewer for Proteomics Results
    Baker, Peter R.
    Chalkley, Robert J.
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2014, 13 (05) : 1392 - 1396
  • [3] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [4] MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
    Cox, Juergen
    Mann, Matthias
    [J]. NATURE BIOTECHNOLOGY, 2008, 26 (12) : 1367 - 1372
  • [5] Impact of Digestion Conditions on Phosphoproteomics
    Dickhut, Clarissa
    Feldmann, Ingo
    Lambert, Joerg
    Zahedi, Rene P.
    [J]. JOURNAL OF PROTEOME RESEARCH, 2014, 13 (06) : 2761 - 2770
  • [6] STRUCTURAL CHARACTERIZATION OF BLOTTING MEMBRANES AND THE INFLUENCE OF MEMBRANE PARAMETERS FOR ELECTROBLOTTING AND SUBSEQUENT AMINO-ACID-SEQUENCE ANALYSIS OF PROTEINS
    ECKERSKORN, C
    LOTTSPEICH, F
    [J]. ELECTROPHORESIS, 1993, 14 (09) : 831 - 838
  • [7] Fernandez J, 2001, CURR PROTOC PROTEIN
  • [8] Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome
    Koiou, Ekaterini
    Tziomalos, Konstantinos
    Dinas, Konstantinos
    Katsikis, Ilias
    Kandaraki, Eleni A.
    Tsourdi, Elena
    Mavridis, Stylianos
    Panidis, Dimitrios
    [J]. ENDOCRINE JOURNAL, 2012, 59 (01) : 21 - 29
  • [9] Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]
  • [10] Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis
    Lee, Young Ho
    Song, Gwan Gyu
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 175 : 8 - 14